Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .

Deep Learning Image Reconstruction for Abdominal CT of Hepatocellular Carcinoma Compared With 3-TESLA MRI

NCT06037343 ·Status: COMPLETED

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

NCT04288323 ·Status: COMPLETED ·Phase: PHASE4

Abbreviated MRI for HCC Surveillance

NCT03731923 ·Status: UNKNOWN ·Phase: NA

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

NCT06658782 ·Status: RECRUITING

Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging

NCT06060769 ·Status: RECRUITING

Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma

NCT03892681 ·Status: UNKNOWN ·Phase: NA

Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions

NCT06816212 ·Status: ENROLLING_BY_INVITATION

Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma

NCT02550613 ·Status: UNKNOWN

Multiparametric MRI for Characterization of Hepatocellular Carcinoma

NCT06999174 ·Status: RECRUITING

Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver

NCT01501240 ·Status: WITHDRAWN

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions

NCT07055048 ·Status: NOT_YET_RECRUITING

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk

NCT07010588 ·Status: NOT_YET_RECRUITING ·Phase: NA

Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules

NCT04687280 ·Status: COMPLETED

Ga-68 Dolacga PET Scan in HCC Under RFA

NCT06792097 ·Status: NOT_YET_RECRUITING

Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma

NCT02585687 ·Status: TERMINATED ·Phase: NA

Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma

NCT01390194 ·Status: COMPLETED

FAST (Focused Abbreviated Screening Technique)-MRI Study

NCT04539717 ·Status: ENROLLING_BY_INVITATION

Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis

NCT00848952 ·Status: UNKNOWN ·Phase: NA

Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma

NCT05327907 ·Status: UNKNOWN

Recurrence of Hepatocellular Carcinoma

NCT01520779 ·Status: COMPLETED

Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients

NCT07080372 ·Status: ACTIVE_NOT_RECRUITING

3T MRI to Predict TACE Response of HCC

NCT02070822 ·Status: UNKNOWN

The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma

NCT05576571 ·Status: UNKNOWN

Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease

NCT06871930 ·Status: NOT_YET_RECRUITING

Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography

NCT05304572 ·Status: COMPLETED